Procept BioRobotics Q4 Loss Widens 65.6%, Revenue Misses by 18.5%
Procept BioRobotics posted a Q4 loss of $0.53 per share, 65.6% worse than the $0.32 consensus and wider than last year’s $0.35 loss. Revenues rose 12% to $76.38 million but missed estimates by 18.5%, contributing to a 13.4% YTD share decline.
1. Q4 Earnings Surprise
The company reported an adjusted loss of $0.53 per share for Q4, missing consensus by $0.21 and representing a 65.6% negative earnings surprise while widening from last year’s $0.35 loss.
2. Revenue Performance
Sales climbed 11.9% year-over-year to $76.38 million but fell short of estimates by 18.5%, marking the second revenue miss in four quarters despite top-line growth.
3. Share Movement
Shares have declined about 13.4% since the start of the year as investors reacted to the earnings and revenue misses, versus a 0.7% gain in the S&P 500 over the same period.
4. Near-Term Outlook
Consensus for the next quarter calls for a $0.31 per share loss on $92.27 million in revenues, while full-year forecasts point to a $1.02 EPS loss on $421.97 million in sales.